Extrusion process for making compositions with poorly compressible therapeutic compounds

Details for Australian Patent Application No. 2010212296 (hide)

Owner Novartis AG

Inventors Serajuddin, Abu T. M.; Kowalski, James; Lakshman, Jay; Vasanthavada, Madhav; Tong, Wei-Qin; Joshi, Yatindra

Agent Davies Collison Cave

Pub. Number AU-B-2010212296

Parent 2006244213

Filing date 12 August 2010

Wipo publication date 2 September 2010

Acceptance publication date 16 June 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

2 September 2010 Application Open to Public Inspection

  Published as AU-B-2010212296

2 September 2010 Complete Application Filed

16 June 2011 Application Accepted

  Published as AU-B-2010212296

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212297-Method of docking an autonomous robot

2010212295-Toe Protection Cap And Footgear Com- prising Toe Protection Cap